PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2010World Journal of Gastroenterology450 citationsOpen Access

Histopathology of nonalcoholic fatty liver disease

EBElizabeth M. Brunt

Key Result

Histological evaluation of liver biopsies remains the standard for assessing hepatic injury and distinguishing steatosis from advanced forms of nonalcoholic fatty liver disease.

Structured PICO

P
Population
Adults and children with nonalcoholic fatty liver disease (NAFLD)
E
Exposure
Histological evaluation via liver biopsy
O
Outcome
Identification of histopathological lesions and distinguishing steatosis from advanced forms of NAFLD (NASH and fibrosis)

Liver biopsy remains the gold standard for diagnosing and distinguishing the severity and specific histological patterns of NAFLD and NASH.

Abstract

Histological analysis of liver biopsies remains a standard against which other methods of assessment for the presence and amount of hepatic injury due to nonalcoholic fatty liver disease (NAFLD) are measured. Histological evaluation remains the sole method of distinguishing steatosis from advanced forms of NAFLD, i.e. nonalcoholic steatohepatitis (NASH) and fibrosis. Included in the lesions of NAFLD are steatosis, lobular and portal inflammation, hepatocyte injury in the forms of ballooning and apoptosis, and fibrosis. However, patterns of these lesions are as distinguishing as the lesions themselves. Liver injury in adults and children due to NAFLD may have different histological patterns. In this review, the rationale for liver biopsy, as well as the histopathological lesions, the microscopically observable patterns of injury, and the differential diagnoses of NAFLD and NASH are discussed.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Elizabeth M. Brunt (2010) conducted a review in Nonalcoholic fatty liver disease (NAFLD). Histological evaluation of liver biopsies was evaluated. Histological evaluation of liver biopsies remains the standard for assessing hepatic injury and distinguishing steatosis from advanced forms of nonalcoholic fatty liver disease.

synapsesocial.com/papers/6a61c10bb3ffb27a727d8ef1https://doi.org/10.3748/wjg.v16.i42.5286
Ask AI
Helpful
Bookmark
Share
View Full Paper